A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ART / antiretroviral

[Related PubMed/MEDLINE]
Total Number of Papers: 144
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ART  (>> Co-occurring Abbreviation)
Long Form:   antiretroviral
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Bundling HIV and TB Care at a District-Level Center in Sierra Leone: A high-yield method for diagnosing co-infection with TB and antiretroviral treatment failure among people living with HIV. KGH, TB
2019 Coding Client Language in Motivational Interviewing for HIV Medication Adherence Using Self-Determination Theory. AM, AM/CM, CT, MI, MISC, SDT
2019 Desimplification of Single Tablet Antiretroviral (ART) Regimens-A Practical Cost-Savings Strategy? ---
2019 Dissociable Contributions of Precuneus and Cerebellum to Subjective and Objective Neuropathy in HIV. ---
2019 Efficacy of Extended-Release Naltrexone on HIV-Related and Drinking Outcomes Among HIV-Positive Patients: A Randomized-Controlled Trial. XR-NTX
2019 Serum ghrelin and obestatin levels in HIV-infected patients: Effect of 36 weeks of antiretroviral treatment. AIP
2018 'Drug adherence levels are falling down again': health worker perceptions of women's service utilization before and after integration of HIV/AIDS services into general care in India. CCCs, CSCs
2018 A first-line antiretroviral therapy-resistant HIV patient with rhinoentomophthoromycosis. ---
2018 Anti-retroviral Status and HIV Transmission Risk Behaviors are Associated with Age, Time Since Diagnosis, and Psychosocial Factors Among Women Living with HIV/AIDS Enrolling in the WILLOW Intervention at Community-Based Organizations. ---
10  2018 Cryptococcal Antigen Screening in Asymptomatic HIV-Infected Antiretroviral Naive Patients in Cameroon and Evaluation of the New Semi-Quantitative Biosynex CryptoPS Test. CM, CM, CrAg, EIA, ICCC, LFA
11  2018 Designing PrEP and early HIV treatment interventions for implementation among female sex workers in South Africa: developing and learning from a formative research process. FGDs, FSWs, PrEP
12  2018 Dolutegravir/Rilpivirine: A Review in HIV-1 Infection. STR
13  2018 Dyslipidemia, chronic inflammation, and subclinical atherosclerosis in children and adolescents infected with HIV: The PositHIVe Health Study. CRP, IL, IMTc, TNF-alpha
14  2018 Evaluation of Oral Antiretroviral Drugs in Mice With Metabolic and Neurologic Complications. ACC, AMPK, NNRTIs, NRTIs, PIs
15  2018 First report of occult hepatitis B infection among ART naive HIV seropositive individuals in Maputo, Mozambique. HBsAg, HBV, HIV, OBI
16  2018 Health Literacy and Demographic Disparities in HIV Care Continuum Outcomes. HIV, PLWH
17  2018 HIV-1 and TB Co-infection in Multinational Resource Limited Settings: Increased neurological dysfunction. ACTG, GEE, NP, RLS, TB
18  2018 Incidence and predictors of single drug discontinuation according to the presence of HCV coinfection in HIV patients from the ICONA Foundation Cohort Study. cART, IR, PYFU
19  2018 Intensification of antiretroviral treatment with raltegravir for pregnant women living with HIV at high risk of vertical transmission. CI, GA, IQR, RAL
20  2018 Potent HIV-1-Specific CD8 T Cell Responses Induced in Mice after Priming with a Multiepitopic DNA-TMEP and Boosting with the HIV Vaccine MVA-B. HIV, MVA, TMEP-B
21  2018 Prevalence and factors associated with renal dysfunction in patients on tenofovir disoproxil fumarate-based antiretroviral regimens for HIV infection in Southern India. TAF, TDF, VL
22  2018 Scaling up implementation of ART: Organizational culture and early mortality of patients initiated on ART in Nairobi, Kenya. LTFU
23  2018 Strength in Amalgamation: Newer Combination Agents for HIV and Implications for Practice. ABC, ATV, COBI, DRV, DTG, EVG, FDC, HIV, INSTI, RPV, STRs, TAF, TDF
24  2018 Which antiretrovirals should be prescribed as first-line treatments? Changes over the past 10 years in France. bPI, NNRTI, NRTI
25  2017 Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort. DAA, EOT, TF
26  2017 Antiretroviral therapy initiation within seven days of enrolment: outcomes and time to undetectable viral load among children at an urban HIV clinic in Uganda. ---
27  2017 Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study. DXA
28  2017 Dynamics of CD4 cell count among HIV-infected individuals in Lagos, Nigeria. HIV
29  2017 Estimating the cost-per-result of a national reflexed Cryptococcal antigenaemia screening program: Forecasting the impact of potential HIV guideline changes and treatment goals. CrAg, DHIS, NHLS
30  2017 High HPgV replication is associated with improved surrogate markers of HIV progression. HPgV
31  2017 HIV Treatment and Re-infection Beliefs Predict Sexual Risk Behavior of Men Who Have Sex With Men. CAI
32  2017 HIV viral kinetics and T cell dynamics in antiretroviral naive persons starting an integrase strand transfer inhibitor and protease inhibitor regimen. INSTI, NRTI, PI
33  2017 HIV/Human herpesvirus co-infections: Impact on tryptophan-kynurenine pathway and immune reconstitution. HHV, HIV, K/T, UMMC
34  2017 Increased soluble IL-7 receptor concentrations associate with improved IL-7 therapy outcomes in SIV-infected ART-treated Rhesus macaques. IL-7
35  2017 Mechanisms of Cognitive Aging in the HIV-Positive Adult. CNS, HAND
36  2017 Performance evaluation of BD FACSPresto™ point of care CD4 analyzer to enumerate CD4 counts for monitoring HIV infected individuals in Nigeria. ---
37  2017 Phased implementation of spaced clinic visits for stable HIV-positive patients in Rwanda to support Treat All. ---
38  2017 Pregnancy and HIV Disease Progression in an Early Infection Cohort from Five African Countries. aHR, CI, PMTCT
39  2017 Relationship Between Single Tablet Antiretroviral Regimen and Adherence to Antiretroviral and Non-Antiretroviral Medications Among Veterans' Affairs Patients with Human Immunodeficiency Virus. AOR, CI, HIV, MTR, STR
40  2017 Risk Factors of Clinical and Immunological Failure in South Indian Cohort on Generic Antiretroviral Therapy. ---
41  2017 Seroprevalence of hepatitis B virus and hepatitis C virus co-infection among people living with HIV/AIDS visiting antiretroviral therapy centres in Nepal: a first nationally representative study. anti-HCV, AOR, CI, HBsAg, HBV, HCV, HIV, KAP, PLHIV
42  2017 The costs of providing antiretroviral therapy services to HIV-infected individuals presenting with advanced HIV disease at public health centres in Dar es Salaam, Tanzania: Findings from a randomised trial evaluating different health care strategies. ---
43  2017 The effect of veno-venous ECMO on the pharmacokinetics of Ritonavir, Darunavir, Tenofovir and Lamivudine. ECMO, PK, VV-ECMO
44  2017 Who will be lost? Identifying patients at risk of loss to follow-up in Malawi. The DREAM Program Experience. CI, LTFU, RR
45  2016 "We Are Now Free to Speak": Qualitative Evaluation of an Education and Empowerment Training for HIV Patients in Namibia. ---
46  2016 A Cognitive Behavioral Therapy-Based Text Messaging Intervention Versus Medical Management for HIV-Infected Substance Users: Study Protocol for a Pilot Randomized Trial. CBT
47  2016 Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in Sao Paulo, Brazil. CrAg, LFA
48  2016 Closing the Gap in Antiretroviral Initiation and Viral Suppression: Time Trends and Racial Disparities. SHRs
49  2016 Community-Based Accompaniment Mitigates Predictors of Negative Outcomes for Adults on Antiretroviral Therapy in Rural Rwanda. CBA
50  2016 Does Awareness of Status and Risks of Human Immunodeficiency Virus Impact Risky Transmission Behavior Among Infected Adolescents? A Case Study of Clients Attending an Antiretroviral Therapy (ART) Clinic in Kano, Kano State, Nigeria. HIV
51  2016 Episodic medication adherence in adolescents and young adults with perinatally acquired HIV: a within-participants approach. IMB
52  2016 Expenditures for Persons Living With HIV Enrolled in Medicaid, 2006-2010. FFS, HIVRN
53  2016 Factors associated with HIV viral load "blips" and the relationship between self-reported adherence and efavirenz blood levels on blip occurrence: a case-control study. NHS, SRA, VL
54  2016 High prevalence of being Overweight and Obese HIV-infected persons, before and after 24months on early ART in the ANRS 12136 Temprano Trial. BMI, WHO
55  2016 HIV-1 Control by NK Cells via Reduced Interaction between KIR2DL2 and HLA-C∗12:02/C∗14:03. HLA, KIRs, NK, pHLA
56  2016 HIV-infected children in the Asia-Pacific region with baseline severe anemia: antiretroviral therapy and outcomes. CI, HIV, IQR
57  2016 HLA Immunogenotype Determines Persistent Human Papillomavirus Virus Infection in HIV-Infected Patients Receiving Antiretroviral Treatment. HIV, HPV
58  2016 Long-term efficacy and safety of etravirine-containing regimens in a real-life cohort of treatment-experienced HIV-1-infected patients. bPI, ETR, MT, VF
59  2016 Longitudinal analysis of the associations between antiretroviral therapy, viraemia and immunosuppression with lipid levels: the D:A:D study. HDL-C, TC, TG, VL
60  2016 Persistence, adherence, and all-cause healthcare costs in atazanavir- and darunavir-treated patients with human immunodeficiency virus in a real-world setting. ATV, DRV, HIV, PDC, PPPM
61  2016 Perspectives and Practice of HIV Disclosure to Children and Adolescents by Health-Care Providers and Caregivers in sub-Saharan Africa: A Systematic Review. HCP, HCPs, SSA
62  2016 Treatment Buddies Improve Clinic Attendance among Women but Not Men on Antiretroviral Therapy in the Nyanza Region of Kenya. ---
63  2016 Understanding Cross-Sectional Racial, Ethnic, and Gender Disparities in Antiretroviral Use and Viral Suppression Among HIV Patients in the United States. MMP
64  2016 Vitamin D status in a Brazilian cohort of adolescents and young adults with perinatally acquired human immunodeficiency virus infection. VitD
65  2015 Autologous aldrithiol-2-inactivated HIV-1 combined with polyinosinic-polycytidylic acid-poly-L-lysine carboxymethylcellulose as a vaccine platform for therapeutic dendritic cell immunotherapy. AT-2, DCs, GMP, Poly-ICLC
66  2015 Challenges in managing HIV in people who use drugs. DAART, DAAs, HCV, OST, PWUD, TB
67  2015 Effect of directly observed antiretroviral therapy compared to self-administered antiretroviral therapy on adherence and virological outcomes among HIV-infected prisoners: a randomized controlled pilot study. DOT, MEMS, SAT
68  2015 Evaluation of the isoniazid preventive therapy (IPT) program in Shurugwi District, Midlands Province, Zimbabwe, January 2013 to August 2014. IEC, IPT, TB
69  2015 Impact of an electronic medical record on the incidence of antiretroviral prescription errors and HIV pharmacist reconciliation on error correction among hospitalized HIV-infected patients. EMR, RR
70  2015 Is zidovudine first-line therapy virologically comparable to tenofovir in resource-limited settings? EFV, NVP, VL
71  2015 Majority of HIV/HCV Patients Need to Switch Antiretroviral Therapy to Accommodate Direct Acting Antivirals. DAA, DDIs, LDV, SMV
72  2015 Optimal therapy of HIV/HCV co-infected patients with direct acting antivirals. DAAs, HCV, IFN
73  2015 Pilot RCT of bidirectional text messaging for ART adherence among nonurban substance users with HIV. PMV, TEXT, UC
74  2015 Severe morbidity after antiretroviral (ART) initiation: active surveillance in HIV care programs, the IeDEA West Africa collaboration. IeDEA
75  2015 SIV-infection-driven changes of pattern recognition receptor expression in mesenteric lymph nodes and gut microbiota dysbiosis. MLN, PRR
76  2015 Trends in hospital deaths among human immunodeficiency virus-infected patients during the antiretroviral therapy era, 1995 to 2011. AIDS, HIV
77  2015 Trends in Prevalence of HIV-1 Drug Resistance in a Public Clinic in Maputo, Mozambique. DRMs, HAART, HIVDR, VL
78  2014 A group-based counselling intervention for depression comorbid with HIV/AIDS using a task shifting approach in South Africa: a randomized controlled pilot study. IPT, MSPSS, PHC
79  2014 Attitudes of people in the UK with HIV who Are Antiretroviral (ART) Naive to starting ART at high CD4 counts for potential health benefit or to prevent HIV transmission. ---
80  2014 Correlates of antiretroviral adherence and viral load among transgender women living with HIV. ---
81  2014 Determinant and outcome of early diagnosis of HIV infection among HIV-exposed infants in southwest Ethiopia. AIDS, ANC, HIV, PMTCT
82  2014 Determinants of Antiretroviral Therapy Adherence among Women in Southern Malawi: Healthcare Providers' Perspectives. ---
83  2014 Increased risk of virological failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort. TD, TF, VF, VL
84  2014 Living well with HIV in Nigeria? Stigma and survival challenges preventing optimum benefit from an ART clinic. ARVs, PLHIV
85  2014 Maraviroc reduces the regulatory T-cell frequency in antiretroviral-naive HIV-infected subjects. cART, HIV, PBMCs
86  2014 Measuring causes of adult mortality in rural northern Malawi over a decade of change. ---
87  2014 Outcome of artemether-lumefantrine treatment for uncomplicated malaria in HIV-infected adult patients on anti-retroviral therapy. ACPR, AL, CI, EFV-arm, HR, NNRTIs, NVP-arm
88  2014 Oxidative stress in HIV patients receiving antiretroviral therapy. CSF, HAART, HIV
89  2014 Pharmacokinetics of lopinavir/ritonavir and efavirenz in food insecure HIV-infected pregnant and breastfeeding women in Tororo, Uganda. EFV, PK
90  2014 Predictors of mortality among patients enrolled on antiretroviral therapy in Aksum hospital, northern Ethiopia: a retrospective cohort study. HR
91  2014 The effect of rational emotive behavior therapy (REBT) on antiretroviral therapeutic adherence and mental health in women infected with HIV/AIDS. REBT, REBT-based therapy
92  2014 Vitamin D insufficiency in HIV-infected pregnant women receiving antiretroviral therapy is not associated with morbidity, mortality or growth impairment in their uninfected infants in Botswana. HEU, IQR
93  2013 Cytomegalovirus DNA in semen and blood is associated with higher levels of proviral HIV DNA. CMV, HIV, MSM
94  2013 Dyslipidemia and fasting glucose impairment among HIV patients three years after the first antiretroviral regimen in a Brazilian AIDS outpatient clinic. IQR
95  2013 Early upper digestive tract side effects of zidovudine with tenofovir plus emtricitabine in West African adults with high CD4 counts. CTX, EFV, NNRTIs, SAEs, ZDV
96  2013 Economic burden of late presentation in HIV disease in Austria: a comparison of the initial costs imposed by advanced HIV disease vs. non-late presentation. ---
97  2013 Emergence of a distinct HIV-specific IL-10-producing CD8+ T-cell subset with immunomodulatory functions during chronic HIV-1 infection. IL-10
98  2013 HIV genotype resistance testing in antiretroviral (ART) exposed Indian children--a need of the hour. GRT, NRTI
99  2013 Hypophosphataemia with non-tenofovir-containing antiretroviral therapy. eGFR
100  2013 Seroprevalence of IgM and IgG antibodies to Toxoplasma infection in healthy and HIV-positive adults from Northern Nigeria. ---